Literature DB >> 7858935

Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome.

S al-Bahar1, R Pandita, B N Dhabhar, E al-Bahar.   

Abstract

A sample of 100 consecutive febrile neutropenic episodes in cancer patients in Kuwait was studied. Acute leukaemias (44%) and lymphomas (29%) were the most frequent underlying cancers; 21 bacteraemis (gram-positive 10, gram-negative 9, polymicrobial 2) were encountered. Staphylococcous epidermidis and Escherichia coli were the commonest organisms. Urinary tract infection occurred in 30% of the microbiologically documented cases. A total of 84 episodes responded to therapy and 9 of the 14 deaths were secondary to infection.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7858935     DOI： 10.1007/bf00344056

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  9 in total

1.  Assessment and reporting of clinical trials of empirical therapy in neutropenic patients.

Authors:  J P Donnelly
Journal:  J Antimicrob Chemother       Date:  1991-03       Impact factor: 5.790

2.  Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.

Authors: 
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

Review 3.  Infection in cancer patients. A continuing association.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

4.  Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.

Authors:  P Martino; A Micozzi; G Gentile; R Raccah; C Girmenia; F Mandelli
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

5.  Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.

Authors:  J Cohen; J P Donnelly; A M Worsley; D Catovsky; J M Goldman; D A Galton
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

6.  Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile.

Authors:  G Günther; M Björkholm; A Björklind; P Engervall; G Stiernstedt
Journal:  Scand J Infect Dis       Date:  1991

7.  Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.

Authors:  I Nováková; P Donnelly; B De Pauw
Journal:  Scand J Infect Dis       Date:  1990

Review 8.  Febrile neutropenia.

Authors:  J Klastersky
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

9.  Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.

Authors:  R Ramphal; M Bolger; D J Oblon; R J Sherertz; J D Malone; K H Rand; M Gilliom; J W Shands; B S Kramer
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191
  9 in total
  5 in total

1.  Role of urine studies in asymptomatic febrile neutropenic patients presenting to the emergency department.

Authors:  Hady Zgheib; Aline El Zakhem; Cynthia Wakil; Mohamad Ali Cheaito; Rola Cheaito; Antoine Finianos; Ralphe Bou Chebl; Rima Kaddoura; Nader Al Souky; Imad El Majzoub
Journal:  World J Emerg Med       Date:  2021

2.  Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman.

Authors:  Maram Abou Saleh; Rose Ngozi Mafiana; Mohammed Al Za'abi; Ragini Vaishnav; Salam Al Kindi; Ibrahim Al-Zakwani
Journal:  Int J Clin Pharm       Date:  2013-10-08

3.  Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer.

Authors:  K V Rolston; N Dholakia; S Rodriguez; E B Rubenstein
Journal:  Support Care Cancer       Date:  1995-11       Impact factor: 3.603

4.  Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia.

Authors:  Mansoor Sirkhazi; Azmi Sarriff; Noorizan Abd Aziz; Fatma Almana; Osama Arafat; Mahmoud Shorman
Journal:  World J Oncol       Date:  2014-12-03

5.  Patterns of microbial growth in urine cultures in a pediatric hematology/oncology unit over a one-year period: a single institution study.

Authors:  Nader Hirmas; Sawsan Mubarak; Iyad Sultan
Journal:  Int J Pediatr Adolesc Med       Date:  2017-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.